Plain-English translation of NCT06053684 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Bronchiolitis is a viral infection that affects the small airways in babies' lungs, making it hard for them to breathe. This trial is testing whether a newer breathing support method called Neurally-Adjusted Ventilatory Assistance (NAVA) works better than standard breathing support for babies in the ICU with severe bronchiolitis. Both methods use a gentle mask or nasal tube to deliver oxygen and help the baby's lungs work less hard, but NAVA is designed to respond more closely to the baby's own breathing efforts.
Standard breathing support for bronchiolitis works well for many babies, but doctors are exploring whether NAVA—a method that syncs more precisely with a baby's natural breathing rhythm—might lead to faster recovery, fewer complications, or less need for more invasive treatment.
You likely qualify if…
You likely don't qualify if…
If your child is enrolled, they will receive one of the two breathing support methods while hospitalized in the ICU. One group receives standard non-invasive ventilation, while the other receives the NAVA method. Both use a specialized nasal mask or tube to deliver oxygen and support breathing without needing a tube down the windpipe. Your child will be monitored closely with standard ICU care, and the research team will track how well each method works and whether your child recovers more quickly.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States